DESIGN THERAPEUTICS INC shareholders Q2 2023

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.

DESIGN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Jump Financial, LLC 12,139$76,4760.00%
JANUS HENDERSON GROUP PLC 829,425$5,225,3770.00%
PRINCIPAL FINANCIAL GROUP INC 728,221$4,587,7980.00%
Cubist Systematic Strategies, LLC 66,686$420,1220.00%
TUDOR INVESTMENT CORP ET AL 20,561$129,5340.00%
China Universal Asset Management Co., Ltd. 733$50.00%
Point72 Middle East FZE 9,085$57,2360.00%
TWO SIGMA INVESTMENTS, LP 115,782$729,4270.00%
Quantbot Technologies LP 4,705$29,6420.00%
WELLINGTON MANAGEMENT GROUP LLP 502,375$3,164,9630.00%
Renaissance Technologies 95,108$5990.00%
Ameritas Investment Partners, Inc. 2,570$16,1910.00%
Tower Research Capital LLC (TRC) 5,300$33,3900.00%
GOLDMAN SACHS GROUP INC 447,416$2,818,7210.00%
BlackRock Inc. 2,994,051$18,862,5230.00%
MARSHALL WACE, LLP 112,922$711,4080.00%
STATE OF WISCONSIN INVESTMENT BOARD 84,000$529,2000.00%
D. E. Shaw & Co., Inc. 135,280$852,2640.00%
METROPOLITAN LIFE INSURANCE CO/NY 2,016$12,7010.00%
MetLife Investment Management, LLC 22,045$138,8840.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q2 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.